Japan performs world’s first commercial iPS heart-cell surgery
A hospital in Japan has performed the world’s first surgery using commercially available heart muscle cell sheets derived from induced pluripotent stem cells (iPS cells), marking a major step in regenerative heart treatment. The procedure was carried out this month at Osaka Keisatsu Hospital in Osaka. A woman in her…